125 related articles for article (PubMed ID: 26016790)
41. Breast, colorectal and prostate cancer screening for cancer survivors and non-cancer patients in community practices.
Hudson SV; Hahn KA; Ohman-Strickland P; Cunningham RS; Miller SM; Crabtree BF
J Gen Intern Med; 2009 Nov; 24 Suppl 2(Suppl 2):S487-90. PubMed ID: 19838855
[TBL] [Abstract][Full Text] [Related]
42. Mammography screening in Italy: 2009 survey.
Giorgi D; Giordano L; Ventura L; Frigerio A; Paci E; Zappa M
Epidemiol Prev; 2011; 35(5-6 Suppl 5):9-27. PubMed ID: 22166347
[TBL] [Abstract][Full Text] [Related]
43. [Cancer: screening inconsistencies].
Hill C
Rev Prat; 2014 Mar; 64(3):307-9. PubMed ID: 24851356
[No Abstract] [Full Text] [Related]
44. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study.
Cluze C; Delafosse P; Seigneurin A; Colonna M
Eur J Cancer Prev; 2009 Sep; 18(5):343-8. PubMed ID: 19436213
[TBL] [Abstract][Full Text] [Related]
45. Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines.
Ulyte A; Wei W; Dressel H; Gruebner O; von Wyl V; Bähler C; Blozik E; Brüngger B; Schwenkglenks M
PLoS One; 2020; 15(4):e0231409. PubMed ID: 32298325
[TBL] [Abstract][Full Text] [Related]
46. Organized colorectal cancer screening programmes: how to optimize efficiency among general practitioners.
Viguier J; Calazel-Benque A; Eisinger F; Pivot X
Eur J Cancer Prev; 2011 Jan; 20 Suppl 1():S26-32. PubMed ID: 21245677
[TBL] [Abstract][Full Text] [Related]
47. Colorectal cancer screening in first-degree relatives of colorectal cancer: participation, knowledge, and barriers against screening.
Gimeno García AZ; Quintero E; Nicolás Pérez D; Hernández M; JiménezSosa A
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1165-71. PubMed ID: 21989122
[TBL] [Abstract][Full Text] [Related]
48. Exploring implications of Medicaid participation and wait times for colorectal screening on early detection efforts in Connecticut--a secret-shopper survey.
Patel VB; Nahar R; Murray B; Salner AL
Conn Med; 2013 Apr; 77(4):197-203. PubMed ID: 23691732
[TBL] [Abstract][Full Text] [Related]
49. Are U.S. cancer screening test patterns consistent with guideline recommendations with respect to the age of screening initiation?
Kadiyala S
BMC Health Serv Res; 2009 Oct; 9():185. PubMed ID: 19821991
[TBL] [Abstract][Full Text] [Related]
50. Diabetes and cancer screening rates among Appalachian and non-Appalachian residents of Kentucky.
Fleming ST; Love MM; Bennett K
J Am Board Fam Med; 2011; 24(6):682-92. PubMed ID: 22086811
[TBL] [Abstract][Full Text] [Related]
51. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Pinsky PF; Blacka A; Kramer BS; Miller A; Prorok PC; Berg C
Clin Trials; 2010 Aug; 7(4):303-11. PubMed ID: 20571134
[TBL] [Abstract][Full Text] [Related]
52. [Chances and risks of prevention in elderly people for the three major cancers: breast-, prostate- and colorectal cancers].
Kolb GF
Zentralbl Gynakol; 2006 Jun; 128(3):123-8. PubMed ID: 16758377
[TBL] [Abstract][Full Text] [Related]
53. The diffusion of screening programmes in Italy, year 2009.
Zappa M; Dardanoni G; Giorgi Rossi P; Grazzini G; Naldoni C; Paci E; Pirola ME; Pizzuti R; Segnan N; Zorzi M; Federici A
Epidemiol Prev; 2011; 35(5-6 Suppl 5):3-7. PubMed ID: 22166346
[TBL] [Abstract][Full Text] [Related]
54. European transnational ecological deprivation index and participation in population-based breast cancer screening programmes in France.
Ouédraogo S; Dabakuyo-Yonli TS; Roussot A; Pornet C; Sarlin N; Lunaud P; Desmidt P; Quantin C; Chauvin F; Dancourt V; Arveux P
Prev Med; 2014 Jun; 63():103-8. PubMed ID: 24345603
[TBL] [Abstract][Full Text] [Related]
55. Cancer screening in Singapore, with particular reference to breast, cervical and colorectal cancer screening.
Yeoh KG; Chew L; Wang SC
J Med Screen; 2006; 13 Suppl 1():S14-9. PubMed ID: 17227636
[TBL] [Abstract][Full Text] [Related]
56. [Organized or individual breast cancer screening: what motivates women?].
Kalecinski J; Régnier-Denois V; Ouédraogo S; Dabakuyo-Yonli TS; Dumas A; Arveux P; Chauvin F
Sante Publique; 2015; 27(2):213-20. PubMed ID: 26414035
[TBL] [Abstract][Full Text] [Related]
57. First report of introducing population-based breast cancer screening in Poland: experience of the 3-million population region of Lower Silesia.
Matkowski R; Szynglarewicz B
Cancer Epidemiol; 2011 Dec; 35(6):e111-5. PubMed ID: 21840281
[TBL] [Abstract][Full Text] [Related]
58. [Colorectal cancer screening programme in France, role of the National Institute of Cancer].
Viguier J; Nathan Mle Q
Med Sci (Paris); 2009 Mar; 25 Spec No 1():45-52. PubMed ID: 19361412
[TBL] [Abstract][Full Text] [Related]
59. [Opportunistic screening of breast cancer in France].
Wait S; Schaffer P; Séradour B; Chollot M; Demay M; Dejouhanet S
Bull Cancer; 1997 Jun; 84(6):619-24. PubMed ID: 9295865
[TBL] [Abstract][Full Text] [Related]
60. [Prostate cancer screening in France: Results from the EDIFICE surveys].
Morère JF; Touboul C; Lhomel C; Rouprêt M
Prog Urol; 2020 May; 30(6):332-338. PubMed ID: 32331954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
